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ABSTRACT
Single nucleotide polymorphisms (SNPs) comprise
the most abundant source of genetic variation in
the human genome. SNPs may be linked to genetic
predispositions, frank disorders or adverse drug
responses, or they may serve as genetic markers in
linkagedisequilibriumanalysis.Thusfar,established
SNP detection techniques have utilized enzymes to
meet the sensitivity and specificity requirements
needed to overcome the high complexity of the
human genome. Herein, we present for the first time
amicroarray-basedmethodthatallowsmultiplexSNP
genotyping in total human genomic DNA without the
need for target amplification or complexityreduction.
This direct SNP genotyping methodology requires
no enzymes and relies on the high sensitivity of the
gold nanoparticle probes. Specificity is derived from
two sequential oligonucleotide hybridizations to
the target by allele-specific surface-immobilized
capture probes and gene-specific oligonucleotide-
functionalized gold nanoparticle probes. Repro-
ducible multiplex SNP detection is demonstrated
withunamplifiedhumangenomicDNAsamplesrepre-
senting all possible genotypes for three genes
involved in thrombotic disorders. The assay format
is simple, rapid and robust pointing to its suitability
for multiplex SNP profiling at the ‘point of care’.
INTRODUCTION
The decoding of the human genome (1,2) and the resulting
greater than 3 million single nucleotide polymorphisms
(SNPs) present exciting avenues to study the impact of genetic
variations on complex phenotypes. Moreover, the ability to
associate disease states and pharmacological responses with
individual SNPs and increasingly with haplotypes (3) and
related linkage disequilibrium mapping studies (4–6) offer
the possibility of improved therapeutic and prophylactic
measures. To realize this promise at the level of the individual,
highly sensitive, robust and inexpensive SNP detection
methodologies are needed.
Numerous strategies have been developed for SNP dis-
crimination with various degrees of multiplexing capability
(7–10). Overcoming the greater than 1000000000 bp com-
plexity presented by the human genomic DNA remains one of
the principal challenges for SNP genotyping (11,12). In allele-
speciﬁc hybridization strategies, reduction in complexity is
achieved by target ampliﬁcation typically with PCR, which
also accommodates any sensitivity limitations. The ampliﬁed
targets can then be interrogated by various direct and indirect
hybridization strategies (7–10). Several strategies have also
been devised that rely on the high speciﬁcity of enzymes
to allow SNP identiﬁcation directly from genomic DNA.
Thermostable ligases have been used in conjunction with
two probes that bind to adjacent regions of the SNP in ‘ligase
chain reactions’ to generate sufﬁcient number of ligated
probes that are detected by FRET (13). Related strategies
combine polymerase extension and ligation of probes, which
are then followed by probe ampliﬁcation to allow detection
(14–17). Flap endonucleases have been employed in
signal ampliﬁcation assays where allele-speciﬁc probes are
displaced by upstream probes at the SNP site on the target
(18). This three-dimensional structure is recognized as a
cleavage sitebytheenzyme.Cleavageresultsinthegeneration
of a fragment that is a substrate for secondary reactions, which
generate FRET probes exponentially to provide detectable
signals. Thus, overcoming genome complexity has, thus far,
not been possible without enzymatic intervention.
We present an enzyme-free, allele-speciﬁc hybridization
methodology for multiplex SNP proﬁling of total genomic
DNA. The assay format employs gold nanoparticle probe-
based hybridization and detection strategies in conjunction
with microarrays (19,20). The SNP detection strategy relies
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speciﬁcity afforded by the sequential hybridizations of
two sequence-speciﬁc probes that selectively ‘sandwich’ the
allele-speciﬁc target. Signiﬁcantly, this simple methodology
eliminates the need for both target ampliﬁcation and complex-





silver enhancer solutions (Sigma A and B), formamide and
human placental DNA were purchased from Sigma-Aldrich.
Additional genotyped human genomic DNA samples were
obtained from the Coriell Institute. 20· SSC was from
GIBCO-BRL. Gaskets used to create multiple test arrays on
each slide were purchased from Grace Biolabs. CodeLink
microarray substrates were purchased from Amersham.
SNP arrays, nanoparticle probes and sequences
EachSNPwasrepresentedbytwoallele-speciﬁccaptureoligo-
nucleotide probes and a gene-speciﬁc probe. The placement of
the SNP site within the capture probes allows the detection of
both alleles in the same reaction well (19). We have shown
previously that placing the SNP site within the signal probe
oligonucleotide also allows SNP discrimination with PCR
products, but requires separate wells toevaluate the two alleles
(20). Amine-modiﬁed capture oligonucleotides and thiol-
modiﬁed probe oligonucleotides used in the multiplex SNP
assay for the three genes were synthesized in-house (ABI 3900
DNA synthesizer) and puriﬁed by HPLC (ion-exchange).
The capture probes were arrayed on CodeLink substrates in
150mMSodiumPhosphatebuffer(pH8.5)supplementedwith
0.01% SDS with an Omnigrid (GeneMachines) arraying
machine. Arraying arrangements on the slide allowed multiple
sub-arrays that could be physically partitioned with silicone
gaskets (Grace Biolabs) to generate separate test wells. Pro-
tocols recommended by the manufacturer were followed for
post-array processing of the test slides.
Goldnanoparticles ( 15 nmdiameter)were prepared by the
citrate reduction method (21). The approximate concentration
of the gold nanoparticles was deduced from equating particle
size measurements obtained by transmission electron micro-
scopy (TEM) to the gold atom concentration, which was
obtained by inductive coupled plasma–atomic emission spec-
troscopy (ICP–AES). Optical spectra of the gold nanoparticles
were recorded with an HP8453 UV-vis spectrophotomer
(lmax = 518 nm). The oligonucleotide-modiﬁed gold nanopar-
ticle probes were synthesized following protocols described
previously (22). Brieﬂy, thiol-functionalized oligonucleotides
(4 mM ﬁnal concentration) were initially incubated with gold
nanoparticles for >16 h, followed by successive additions of
phosphate-buffered saline (PBS) to a ﬁnal concentration of
0.8 M NaCl. After an overnight incubation, the probes were
isolated by centrifugation, washed in an equivalent amount of
water, and then redispersed in 0.1 M PBS, 0.01% azide at a
particle concentration of 10 nM. Allprobes were stored at4 C.
The sequences for oligonucleotide pairs for each SNP were
designed such that the capture probe contained the mutation
site and the probe oligonucleotide covered a neighboring
region either 30 or 50 to the capture oligonucleotide site.
The number of bases separating the capture and the probe
oligonucleotide was typically no more than  50 nt. The
capture probes and the probe oligonucleotides for all SNPs
were designed to function under isothermal assay conditions.
NB: For convenience, the major and the minor alleles are
referred to as wild-type (or wt) and mutant (mut) respectively.
Sequences for the capture and the probe oligonucleotides
employed in the assays are listed: MTHFR wt, 50-GATGA-
AATCGGCTCCCGCAGAC-30; MTHFR mut, 50-ATGAAA-
TCGACTCCCGCAGACA-30; MTHFR probe, 50-GGAA-
GAATGTGTCAGCCTCAAAGAAAAGC-30; factor V wt,
50-TGGACAGGCGAGGAATACAGGTAT-30; factor V mut,
50-CTGGACAGGCAAGGAATACAGGTATT-30; factor V
probe, 50-CCACAGAAAATGATGCCCAGTGCTTAACAA-
GACCATACTACAGTGA-30; factor II wt, 50-CTCAGCG-
AGCCTCAATGCTCCC-30; factor II mut, 50-CTCTCAG-




Human placenta DNA (Sigma) or patient genomic DNA
samples (Coriell Institute) were independently genotyped by
sequencing methods. The DNA sample was fragmented by
ultrasonication (Misonix), and conditions were adjusted to
yield a median DNA length of  0.5 kb. The target hybridiza-
tion mixture (5 ml) contained 4· SSC, 0.05% Tween-20, 35%
formamide, and 0.5–5 mg human genomic DNA, or as indi-
cated in the speciﬁc experiment. The hybridization mixture
was added to the testwell after a 3min, 98 C heat denaturation
step. Each test slide possessed several sub-arrays that could
be isolated by gaskets allowing for the testing of several test
samples simultaneously. The test slide was incubated at
40 Cfor60minandwashedsubsequentlyatroom temperature
twice (2 min each) in a wash buffer containing 0.5 M NaNO3,
0.05% Tween
TM-20. This low stringency wash was followed
by a brief high stringency wash (30 s) in a low-salt wash buffer
(0.4· SSC). Each sub-array was then covered with 50 ml
hybridization buffer (4· SSC, 0.05% Tween-20, 35% forma-
mide) containing gold-nanoparticle probes (1 nM each) for
30 min at 40 C. The isolating gasket was removed and the
test slide was washed again in the wash buffer for 3 min (2·)
at room temperature with gentle agitation. Finally, the washed
slide was stained with 2 ml of silver reagent, an admix of
SilverenhancerAandBsolutions(Sigma)for 5min,washed
in ddH2O, and dried. The dried slide was imaged with a
Nanosphere Verigene ID
TM imaging system or with an array-
Worx biochip reader (Applied Precision).
Data analysis
The images captured by either system (Verigene ID
TM or
arrayWorx biochip reader) comprise 16-bit ﬁle formats.
Mean signal intensities were obtained by correcting for
local background using commercially available analysis soft-
ware [GenePix Pro 4.0 (Axon) or the dedicated software on
the arrayWorx biochip reader]. The triplicate signals for
each capture oligonucleotide were averaged to obtain mean
net signals (S). Discrimination factors (DF) were calculated
using the following normalizing algorithm:
DF ¼ Swt Smut ðÞ = Swt þ Smut ðÞ
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afteradding3SDvaluestotheaverageheterozygousDFvalue.
These threshold values allow genotype calls for unknowns
with a greater than 99% conﬁdence: DF values between
+0.4 and  0.4 are called heterozygous and values below and
above this range are called homozygous mutant and homo-
zygous wild-type, respectively.
RESULTS AND DISCUSSION
The microarray-based methodology employed for SNP dis-
crimination involves hybridization of two oligonucleotide
probes, the capture and the signal probe, to the DNA target
sequence (19). The allele-speciﬁc capture probe covers the
SNP site and is immobilized on a glass slide surface. The
signal probe, on the other hand, is covalently bound to gold
nanoparticles, which hybridize to a sequence neighboring the
SNP site. The basic steps for the SNP assay are outlined in
Figure 1. Brieﬂy, genomic DNA is fragmented and hybridized
to a microarray containing allele-speciﬁc capture probes under
conditions that are sufﬁciently stringent to allow allele-
speciﬁc hybridization of the targets. After this hybridization
step, unbound genomic DNA is removed in a wash step and
followed by a second hybridization step designed to attach
oligonucleotide-modiﬁed gold nanoparticle probes to the
captured targets, so as to ‘sandwich’ the target between immo-
bilized capture probes and gold nanoparticle probes. After
removal of all unbound nanoparticle probes, a silver develop-
ment step is used to precipitate elementary silver around the
nanoparticle probes (23), which dramatically increases their
extinction and improves their ability to scatter light by several
orders of magnitude (20).
For detection, the light source, either white light or
light from LEDs (lmax: 630 nm), is delivered into the plane
of the test slide. The resulting evanescent wave excites the
silver-ampliﬁed gold nanoparticles and the scattered light is
focused onto a photosensor to capture the image. This scatter-
based detection method provides ultra-high sensitivity with
an ability to distinguish diffraction-limited single silver-
ampliﬁed gold nanoparticles (20).
As a model for SNP detection in total genomic DNA,
SNPs in three coagulation genes associated with thrombotic
disorders were chosen (24), factor V (1691 G!A), factor II
(20210 G!A) and MTHFR (677 C!T). The arrays contained
twoallele-speciﬁccaptureprobesforeachSNP(seeFigure2a),
one representing the wild-type (wt) sequence and the other
containing the speciﬁc nucleotide change (mutant or mut). All
capture probe sequences were designed to be isothermal such
that similar assay conditions could be used for SNP discrimi-
nationofthethreegenes.Assayoptimizations revolved around
establishing hybridization stringencies for reliable SNP dis-
crimination. Salt, temperature and formamide were varied to
achieve stringency conditions that allowed multiplex SNP
discrimination. Genomic DNA samples, obtained from com-
mercial sources, were sequenced by a third-party vendor to
conﬁrm the genotypes of the three genes (factor V, factor II
and MTHFR). As shown in Table 1, these samples collectively
represented all possible genotypes (wild-type, mutant and het-
erozygous) for each of the three SNPs. A typical scatter image
from a multiplex SNP assay is presented in Figure 2b along
with the associated quantitation. The genomic DNA sample
GM 16000 was heterozygous for MTHFR (677 C!T), homo-
zygous mutant for factor II (20210 G!A), and homozygous
wild-type for factor V (1691 G!A). When hybridized to the
SNP array using the optimized assay conditions, quantitation
of the net signal intensities gave a relative value of >20000
for both the wild-type and mutant MTHFR capture spots. The
Swt/Smut ratio of 1.1 indicates a heterozygous genotype. For
factor II, the signal intensities at the mutant capture spots were
10-fold greater than the wild-type capture spots to give a Swt/
Smut ratio of <0.1 pointing to a homozygous mutant genotype.
The Swt/Smut ratio for factor V was >5, conﬁrming a homo-
zygous wild-type genotype. Quantitative data for four addi-
tional genomic DNA samples that were also subjected to the
genotyping assays is presented (Figure 2c–f). Each of the
determinations was consistent with the data obtained from
sequencing results of the genomic DNA samples, providing
further evidence that the gold nanoparticle-based assay is cap-
able of accurately identifying homozygous as well as hetero-
zygous genotypes, from complex, unampliﬁed genomic DNA.
The basis for these extraordinary observations is the
combined speciﬁcities of two hybridization reactions and
the high sensitivity afforded by the gold nanoparticle probes.
The assay design requires a sequential hybridization of the
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Figure 1. Fragmented unamplified genomic DNA and gold nanoparticle probes are sequentially hybridized to the SNP microarray containing capture probes
representing the two possible alleles. After the two hybridization steps, the array is subjected to stringency washes and a silver development step. The scatter signal
from the test sites is imaged subsequently to obtain genotyping results.
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step, fragmented genomic DNA is hybridized to the chip at
high stringencies that allow allele-speciﬁc hybridization of the
target molecules. But because of the extremely high complex-
ity of human genomic DNA, it is likely that a signiﬁcant
number ofnon-target sequences are able toform stable hybrids
with the capture probes. These sequences would include
homologous sequences as are found by searches performed
in available sequence databases. Additionally, various
‘pseudo-homologous’ hybrids, including bulge structures or
long DNA fragments hybridized to multiple capture probes,
may also form stable structures at the test sites. Indeed the
number of non-target hybridization events could surpass those
with true gene-speciﬁc targets even though under these condi-
tions there is single base discrimination between the speciﬁc
wild-type and the mutant targets. While the high stringency
wash at the end of the ﬁrst step aims to remove unbound
genomic DNA and dramatically reduces overall complexity
for the second step hybridization, it is not expected to elim-
inate theboundhomologousorpseudo-homologousnon-target
DNA from the test sites. Thus, in the context of this assay,
identifying the allele-speciﬁc targets hybridized at each
test site in the midst of captured non-target DNA requires a
second speciﬁc hybridization event. It is reasonable, however,
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Figure 2. MultiplexdetectionofSNPsfromunamplifiedgenomicDNAfromfivedifferentgenomicDNAsamples.(a)Allele-specificcaptureoligonucleotidesfor
the hypercoagulation genes (MTHFR, FII and FV) were spotted in triplicate in the arrangement indicated. The microarrays (b–f) were subjected to unamplified
genomic DNA from the different samples followed by gene-specific probes. The abbreviations used to identify the different DNA samples were adopted from
the vendor (Coriell Institute). The samples embodiedall three genotypes for the individual genes (wild-type, mutant and heterozygous) and can be identified by the
presenceorabsenceofsignalattherespectivecaptures[seeimagein(b)].Thegraphsassociatedwithindividualimagesrepresentaveragenetsignalvaluesfromthe
triplicate spots for the wild-type (wt) or mutant (mut) capture spots, respectively. Error bars correspond to 1 SD.
Table 1. Enzyme-free genotyping with nanoparticle probes
Gene GM16000 GM00037 GM14899 GM14650 GM16028 Placenta DNA
MTHFR Heterozygous Mutant Wild-type Wild-type Heterozygous Wild-type
FII Mutant Heterozygous Wild-type Wild-type Heterozygous Wild-type
FV Wild-type Wild-type Mutant Heterozygous Heterozygous Wild-type
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site is signiﬁcantly lower than that of total human DNA. The
second hybridization, accomplished by the gene-speciﬁc
nanoparticle probe, provides the discrimination power to dis-
tinguish targets from non-targets and in the process allows
SNP identiﬁcation.
In order to conﬁrm the need for two hybridizations for SNP
discrimination, fragmented genomic DNA was subjected to a
terminaltransferasereactioninthepresenceofdATPtotailthe
ends of each DNA fragment with stretches of poly(dA)
sequences. This tailed genomic DNA was then hybridized to
the SNP array by using the standard protocol except that the
second step of the assay was performed either with poly(dT)-
modiﬁed 15 nm gold probes or with the gene-speciﬁc probes.
As expected, the assay with the gene-speciﬁc probes yielded
signals only at the wild-type capture spots indicative of
the correct genotype (Figure 3a). In contrast, the poly(dT)-
modiﬁed probes exhibited strong signals both at the wild-
type and mutant test capture spots (Figure 3b). Even though
the signals were strong, they did not allow proper genotyping.
Striking is the inordinately high signal (10- to 40-fold) asso-
ciated with the poly(dT) probe when compared with the assay
performed with gene-speciﬁc probes. Since the molarity of the
poly(dT) probe as well as the gene-speciﬁc probes was iden-
tical, the higher signal associated with the poly(dT) probe
would suggest that a greater number of probes are bound at
the test sites. While some of this may be due to the binding of
multiple probes at each poly(A) tail, we have evidence that
probes in close physical proximity are covered by the same
silverreaction,generatingonlyasmallincreaseinsignal.Thus,
the increasein signal may be explainedby the presence ofnon-
target homologous and pseudo-homologous DNA sequences
bound to the test sites along with the gene-speciﬁc target.
Signiﬁcant to the mechanism of this assay is the observation
that gene-speciﬁc probes are able to provide accurate genotyp-
ing even in the presence of apparently a signiﬁcant amount of
non-targetDNA.Theboundnon-targetDNAdoesnotinterfere
with theassaybecause thegene-speciﬁc probesaredesigned to
hybridize to an adjacent region of the SNP site, and the prob-
ability of a non-target DNA fragment possessing also a homo-
logous region for the nanoparticle probe is extremely low.
In order to estimate assay detection limits, the input amount
of factor V mutant human genomic DNA was reduced to 2.5,
1 and 0.5 mgi na5ml reaction volume, corresponding to
750000, 300000 and 150000 genome copies or 250, 100
and 50 fM respectively (Figure 4). As expected, attenuation
of signal-to-noise ratios was observed with decreasing target
concentration. Nevertheless, reliable SNP discrimination was
observed at all concentrations including at 0.5 mg genomic
DNA based on  15 separate experiments; at lower amounts
(0.1 mg or 30000 genome copies) the genotyping call rates fell
to  50% primarily because target signals dropped below 3 SD
of background signals. We attribute the ability to detect SNPs
with 150000 genome copies (500 ng in 5 ml; 50 fM) of human
genomic DNA in a  1 h hybridization to the high sensitivity
afforded by the gold nanoparticle probes. This would be
difﬁcult to achieve by standard detection techniques using
ﬂuorophores, judging by the greater than 3 log higher
detection limits of nanoparticles over ﬂuorophores that we
have observed in a particle-to-ﬂuorophore comparison
(0.001 probes/mm
2 versus 7 ﬂuors/mm
2) (20).
In order to test the reproducibility of this assay system,
a total of 25 independenthybridization assays were performed,
each with triplicate SNP testing for all three thromobosis
genes. A total of six unique genomic DNA samples (Table 1)
were included in the reproducibility studies. This represented













































Figure 3. SNP discrimination requires the specificity provided by the
sequential hybridization of target-specific capture and probes. Fragmented
human placenta DNA (wild-type for FV, FII and MTHFR) was tailed with
poly(dA) by terminal transferase. The poly(dA) tailed genomic DNA was
hybridized to SNP arrays (5 mg/array) at 35% formamide, 4· SSC, 0.01%
Tween and 0.01% SDS at 40 C for 1 h. After removing unbound genomic
DNA targets, the arrays were further hybridized with either gene-specific
probes (a) or poly(dT) nanoparticle probes (b) for 30 min and followed by a
silverenhancingstep,respectively.(a)Gene-specificprobesemployedforSNP
discrimination of the poly-dA labeled genomic DNA showed clear differences
between the intensities at the wt and mut captures permitting SNP discri-
mination even in the presence of non-target homologous DNA at the test sites.
(b) With the poly(dT) probes, strong signals were observed both at the wt and
mut capture oligonucleotides but SNP discrimination was not possible indicat-
ing that the signals derive from non-target homologous DNA.
FV mut FV mut gen. D gen. DNA
















Figure 4. Detection sensitivity of the SNP discrimination assays in genomic
DNA. SNP arrays for the factor V gene were hybridized with 2.5 mg (750000
copies), 1 mg (300000 copies) and 500 ng (150000 copies) of unamplified
human genomic DNA genotyped to be mutant for the factor V gene in a target
titrationexperiment.ClearSNPdiscriminationwaspossibleevenat500ngtotal
genomic DNA.
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described (see Materials and Methods) and averaged for each
genotype (Figure 5a–c): DF factor V wt = 0.72, het =  0.06
and mut =  0.78; DF factor II wt = 0.66, het =  0.07 and
mut= 0.88;DFMTHFRwt=0.8,het=0.06andmut= 0.68
(Figure 5). Although the sequence context is different for the
three polymorphic sites, the DF for a certain allelic status
showed low variability between the different SNPs (as low
as 1% for heterozygous DFs to a maximum of 20% for mutant
DFs).Thus,weaveragedthevaluesforeachgenotype(0.72for
wild-type, 0.77formutant,and 0.02forheterozygous),and
set a threshold at +/  0.4 by adding 3 SD values to the mean
heterozygous DF value (Figure 5d). Since none of the homo-
zygous or heterozygous genotypes had DF values that fell
below these threshold values, it appears that this method
would allow detection of an SNP in an unknown genotype
with a >99% conﬁdence level.
CONCLUSION
SNP genotyping on microarrays with total genomic DNA is
possible owing to the high assay speciﬁcity derived by sand-
wichingthetargetbetweencaptureanddetectionprobesintwo
sequential steps coupled with the ultra-high sensitivity of gold
nanoparticle probes. The superior assay sensitivity is critical
especially when hybridizations are performed within one hour
with a target requirement of as little as 500 ng total genomic
DNA—an amount obtained from a single drop of blood or
from a buccal swab. The ability to discriminate single base
changes with unampliﬁed genomic DNA and the simplicity,
low-cost and robustness of this assay points to a genotyping
solution for ‘point of care’ diagnostic applications.
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75 separate genotyping determinations. Of these, 35 determinations were from wild-type placenta DNA. The remaining 40 determinations (30 heterozygous and
10 mutants) came from genomic DNA samples from Coriell Institute (refer to Table 1). From the individual DF values for each gene, the average DF values were
calculated for wt, mut and het, respectively (a–c). Average DF values for all three genes were plotted and a threshold to distinguish between heterozygous and
homozygous genotypes was set at –0.4 after factoring in 3 SD values above the average heterozygous signal (d).
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